18 F labeling strategies for unmodified peptides with [ 18 F]fluoride require 18 F-labeled prosthetics for bioconjugation more often with cysteine thiols or lysine amines. Here we explore selective radical chemistry to target aromatic residues applying C− H 18 F-trifluoromethylation. We report a one-step route to [ 18 F]CF 3 SO 2 NH 4 from [ 18 F]fluoride and its application to direct [ 18 F]CF 3 incorporation at tryptophan or tyrosine residues using unmodified peptides as complex as recombinant human insulin. The fully automated radiosynthesis of octreotide[Trp(2-CF 2 18 F)] enables in vivo positron emission tomography imaging. Figure 1. Direct 18 F-trifluoromethylation of native residues in unmodified peptides. Communication pubs.acs.org/JACS
P ositron emission tomography (PET) is a powerful molecular imaging modality for diagnosis, monitoring disease progression, studying biological processes in vivo, and investigating the efficacy of drugs. 1−3 Among the radioisotopes employed for the preparation of PET probes, 18 F is a widely used and clinically relevant radionuclide. 2 Because of its short half-life (t 1/2 = 109.7 min), 18 F must be incorporated into tracer molecules at a late stage of the synthetic process. 4, 5 Additional challenges imposed by radiochemistry include low reaction concentration, solvent compatibility, and the fact that cyclotron-produced 18 F sources are limited to 18 F-fluoride and [ 18 F]F 2 . These constraints are stringent for biomolecules. 18 F-radiolabeled peptides can be used to measure the distribution and pharmacokinetics of peptide-based therapeutics and serve as imaging biomarkers for therapy. 6, 7 These benefits have encouraged the development of methods for tagging peptides with radioactive functional groups. 8−10 Fluorine-18 is incorporated into prefunctionalized peptides via direct C− 18 F, B− 18 F, and Si− 18 F bond formation or chelation with Al− 18 F. 11−14 Alternatively, an 18 F-labeled prosthetic group is prepared prior to bioconjugation. To preserve function, this latter conjugation ideally proceeds under mild reaction conditions. 15−19 Such strategies require handles with unique reactivity either by, e.g., prior installation of unnatural amino acids or by taking advantage of the inherent reactivity of natural amino acids. To date, the latter has almost exclusively exploited the nucleophilicity of cysteine thiols 20 or lysine amines 21 to attach the 18 F-prosthetic group. Although the structural alteration imposed by the 18 Fprosthetic group is typically tolerated, it could alter the efficacy and/or function. 1c Therefore, innovative methods that employ [ 18 F]fluoride and target native residues in unmodified peptides with 18 F 22 or a minimally sized 18 F-prosthetic (e.g., [ 18 F]CF 3 ) are of considerable value.
We reported the 18 F-trifluoromethylation of native peptides with 5-18 F-(trifluoromethyl)dibenzothiophenium trifluoromethanesulfonate, a method modifying cysteine thiols ( Figure  1A ). 23 We also applied tuned radical chemistry to program C− H 19 F-trifluoromethylation of aromatic residues in proteins. 24a Sodium trifluoromethanesulfinate (NaTFMS, Langlois' re-agent) displayed selective reactivity for tryptophan under redox initiation. Recently, Krska et al. demonstrated that Zn(TFMS) 2 (Baran's reagent), when activated with a stoichiometric oxidant or via visible-light photoredox catalysis, enabled trifluoromethylation of tyrosine in peptides that do not contain tryptophan residues. 25 These precedents encouraged us to produce 18 F-trifluoromethanesulfinate for selective C−H 18 Ftrifluoromethylation of these aromatic amino acid residues within unmodified peptides. This approach would generate noncanonical [ 18 F]CF 3 -tryptophan and -tyrosine residues, a transformation unmatched by alternative 18 F labeling methods ( Figure 1B) .
Routes toward trifluoromethanesulfinic acid salts include metal or electroreduction of a mixture of SO 2 and CF 3 Br in N,N-dimethylformamide (DMF), 26 treatment of CF 3 Cl with Na 2 S 2 O 4 , 27 or multistep syntheses from trifluoromethylsulfone precursors (Scheme 1A). 28 For 18 F radiochemistry, these approaches would require a route toward the [ 18 F]CF 3 precursor and one or more reactions postlabeling. Our design plan was to construct [ 18 F]CF 3 SO 2 − in one step by applying a multicomponent approach that combines 18 F-fluoride, a difluorocarbene source, and SO 2 . The formation of [ 18 F]CF 3 − from difluorocarbene and [ 18 F]F − is known, 29−31 so the challenge was to validate a protocol that couples in situgenerated [ 18 F]CF 3 − with SO 2 (or a surrogate of this gaseous and toxic reagent) (Scheme 1B).
Exploratory studies performed with 19 F-fluoride provided useful information. 32 The difluorocarbene and SO 2 sources were found to be critical in enabling the construction of 33 or N-methylmorpholine·SO 2 (NMM·SO 2 ) in the presence of KF/ K 222 in DMF at 100°C afforded the ammonium salt of CF 3 SO 2 − in 31% or 44% yield, respectively, after isolation by semipreparative HPLC. A saturated solution of SO 2 in DMF did not lead to product formation, while ClF 2 CCO 2 Me in combination with PPh 3 was the only alternative difluorocarbene source found to be suitable for this process. For 18 F labeling, PDFA was elected as the optimal reagent. In contrast to experiments carried out with fluoride, DABSO and PDFA afforded [ 18 F]CF 3 SO 2 K in trace amounts (Scheme 2A). However, the combination of PDFA, NMM·SO 2 and [ 18 F]KF/K 222 gave [ 18 F]CF 3 SO 2 K in 22% radiochemical conversion (RCC). These results encouraged the development of a manual protocol to prepare, purify, and isolate this novel 18 F reagent for subsequent use (Scheme 2B). PDFA is thermally unstable and poorly soluble in DMF, so a mixture of this reagent and NMM·SO 2 was added as a suspension in a suitable solvent to azeotropically dried 18 F-fluoride. Among all solvents tested, propylene carbonate (PC) was best when used with DMF. 34 Additional optimization tuning reagents, ratios of various components, and concentrations proved to be beneficial. The optimal process consisted of reacting PDFA (0.16 mmol) and NMM·SO 2 (0.06 mmol) with [ F) was obtained in 22% and 18% RCC, respectively. Two additional regioisomers resulting from competitive 18 F labeling at C4 and C7 were also formed, giving a combined RCC of 10% or 9% when Fe(NO 3 ) 3 ·9H 2 O or FeCl 3 , respectively, was employed. 37 A series of dipeptides was evaluated, focusing on feasibility and selectivity (Scheme 3). 32 For reactions leading to more than one 18 25 Next, we studied biologically relevant peptides of increasing complexity. The dipeptide immunomodulator thymogen (oglufanide) 38 was 18 F-trifluoromethylated at Trp with an isolated radiochemical yield (RCY) calculated from [ 18 F]-CF 3 SO 2 NH 4 of 39%. Endomorphin-1, a tetrapeptide associated with Alzheimer's disease, 39, 40 underwent Trp-selective 18 F labeling in 23% RCY, and somatostatin-14, a cyclic tetradecapeptidic hormone with a broad inhibitory effect on endocrine secretion, was 18 F-labeled in 20% RCY. 41 The 18 Ftrifluoromethylations of melittin, 42 a 26-residue venom peptide, and octreotide, 43 an octapeptide that mimics natural somatostatin, were equally successful (14% RCC and 29% RCC, respectively). Tyrosine-containing peptides were examined next. Angiotensin fragment 1−7, a peptide with antiinflammatory properties, 44, 45 and c(RGDyK), a peptide ligand of integrin α v β 3 receptors, 46 Journal of the American Chemical Society pubs.acs.org/JACS Communication trifluoromethylation of a much larger peptide, recombinant human insulin (MW = 5808 Da), was also considered. 47 This experiment was carried out with insulin (5.2 μmol), Fe(NO 3 ) 3 · 9H 2 O (5.8 equiv), and TBHP (11.5 equiv) in DMSO/aqueous ammonium formate and afforded [ 18 F]CF 3 -insulin in 34% overall RCC as a mixture of four products resulting from [ 18 F]CF 3 incorporation at all tyrosine residues. The main site of 18 F-trifluoromethylation was at chain A residue Y19, a result consistent with the report of Krska et al. 25 To date, automated radiosyntheses have focused on small molecules but rarely on peptides. 48 To demonstrate translational applicability, we developed a fully automated radiosynthesis of octreotide[Trp(2-CF 2 18 F)] on the Advion NanoTek microfluidic synthesis system (Figure 2 ). 32 The automated radiosynthesis of [ 18 F]CF 3 SO 2 NH 4 required optimization of selected steps. The addition of the suspension of PDFA and NMM·SO 2 in PC/DMF to a vial containing [ 18 F]KF was not compatible with automation. This issue was solved by changing the difluorocarbene source to ClF 2 CCO 2 Me, a reagent activated with (2-biphenyl)di-tert-butylphosphine (JohnPhos), and the solvent to DMA; no change was required for NMM·SO 2 . With these modifications, starting from up to 45 GBq of [ 18 F]fluoride, [ 18 F]CF 3 SO 2 NH 4 was produced in up to 6% ± 1% activity yield (non-decay-corrected, n = 2) after semipreparative HPLC (A m = 1.13 GBq/μmol, synthesis time = 40 min). Removal of HPLC solvents was necessary to afford dry [ 18 F]CF 3 SO 2 NH 4 required for peptide 18 In conclusion, we have reported the first protocol enabling direct 18 F labeling of unmodified peptides at tryptophan and tyrosine residues (with high selectivity for tryptophan) via direct C−H 18 F-trifluoromethylation. This method is a new tool to accelerate the discovery of 18 F-peptides as imaging agents as well as the development of peptide-based drugs. The strategy required the novel 18 
